2023 annual financial data
Prelude Therapeutics 2023 Net income growth
Direct answer
Net income growth was -13.51%.
Operating income was -132,276,999 USD and net income was -121,832,000 USD.
Operating cash flow was -107,063,000 USD.
Get free Prelude Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -132,276,999 USD
- Net income
- -121,832,000 USD
- Operating cash flow
- -107,063,000 USD